Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;476(7):2877-2885.
doi: 10.1007/s11010-021-04122-4. Epub 2021 Mar 19.

The most important biomarker associated with coagulation and inflammation among COVID-19 patients

Affiliations
Review

The most important biomarker associated with coagulation and inflammation among COVID-19 patients

Ling-Zhi Hong et al. Mol Cell Biochem. 2021 Jul.

Abstract

Coronavirus disease 2019 (COVID-19) induced by SARS-Cov-2 can be related to coagulopathy. Also, the infection-induced inflammatory changes are found in patients with disseminated intravascular coagulopathy (DIC). The lack of previous immunity to COVID-19 has caused infection of a large number of patients worldwide and unpredictability regarding the management of the complications that appear in the course of this viral illness. Lungs are the most important target organ of the SARS-COV-2. In COVID-19 patients, acute lung injury leads to respiratory failure. However, multiorgan failure can also occur in these patients. The primary coagulopathy of COVID-19 is marked by a considerable elevation of D-dimer, ferritin, and fibrinogen degradation products. In comparison, abnormalities in platelet count, prothrombin time, and partial thromboplastin time are partly uncommon in initial presentations. Inflammatory biomarkers including CRP, LDH, and IL-6 are significantly elevated in the early stages of the disease. In this regard, inflammation-associated biomarkers and coagulation test screening, including the assessment of IL-6, CRP, LDH, D-dimer, platelet count, PT&PTT time, ferritin, and fibrinogen levels are suggested for detecting infection by this virus. Overall, COVID-19-associated coagulopathy should be managed like other patients with critical conditions, and supportive care and thromboembolic prophylaxis should be used for severe patients.

Keywords: COVID-19; Coagulation; D-dimer.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest in this work.

Figures

Fig. 1
Fig. 1
In COVID-19 patients, activation of coagulation-related factors and the immune system leads to blood clots in the vessels. Activation of coagulation in the pulmonary artery causes pulmonary embolism. These factors cause changes in coagulation-related biomarkers (D-dimer, CRP, PT and PTT, IL-6, fibrinogen, platelet count, LDH, neutrophil and lymphocyte). C-reactive protein (CRP), partial thromboplastin time (PTT), prothrombin time (PT), Interleukin-6 (IL-6), lactate dehydrogenase (LDH)

References

    1. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523. - PMC - PubMed
    1. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. - PMC - PubMed
    1. Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo JP. Comparison of confirmed COVID-19 with SARS and MERS cases-clinical characteristics, laboratory findings, radiographic signs and outcomes: a systematic review and meta-analysis. Rev Med Virol. 2020;30(4):e2112. - PMC - PubMed
    1. Pormohammad A, Ghorbani S, Baradaran B, Khatami A, Turner R, Mansournia MA, Kyriacou DN, Idrovo JP, Bahr NC. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: a systematic review and meta-analysis. Microb Pathog. 2020;147:104390. doi: 10.1016/j.micpath.2020.104390. - DOI - PMC - PubMed
    1. Hui D, Chan M, Wu A, Ng P. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J. 2004;80(945):373–381. - PMC - PubMed